share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 4 17:43
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Patrick Burnett is set to sell 4,782 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold have an aggregate market value of $53,181. Burnett acquired these shares through restricted stock vesting on two separate dates, with 3,855 shares vested on 03/01/2024 and an additional 927 shares on 03/03/2024, both from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,325 shares in the past three months, which had gross proceeds of $4,691.
Arcutis Biotherapeutics, Inc. officer Patrick Burnett is set to sell 4,782 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold have an aggregate market value of $53,181. Burnett acquired these shares through restricted stock vesting on two separate dates, with 3,855 shares vested on 03/01/2024 and an additional 927 shares on 03/03/2024, both from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,325 shares in the past three months, which had gross proceeds of $4,691.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more